A coronavirus-mimic mesoporous silica nanosystem enables efficient targeted delivery of siRNA for anti-SARS-CoV‐2

WHO Coronavirus (COVID-19) Dashboard, https://covid19.who.int (accessed 2023-05-28). Krammer, 2020, SARS-CoV-2 vaccines in development, Nature, 586, 516, 10.1038/s41586-020-2798-3 Wu, 2020, A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2, Science, 368, 1274, 10.1126/science.abc2241 Deng, 2014, Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies, Gene, 538, 217, 10.1016/j.gene.2013.12.019 López-Fraga, 2008, RNA interference-based therapeutics: new strategies to fight infectious disease, Infect. Disord. Drug Targets, 8, 262, 10.2174/187152608786734223 Zhang, 2018, Recent advances in siRNA delivery for cancer therapy using smart nanocarriers, Drug Discov. Today, 23, 900, 10.1016/j.drudis.2018.01.042 Uludag, 2020, Prospects for RNAi therapy of COVID-19, Front. Bioeng. Biotechnol., 8, 916, 10.3389/fbioe.2020.00916 Bobbin, 2016, RNA interference (RNAi)-based therapeutics: delivering on the promise?, Annu. Rev. Pharmacol. Toxicol., 56, 103, 10.1146/annurev-pharmtox-010715-103633 Draz, 2014, Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections, Theranostics, 4, 872, 10.7150/thno.9404 Subhan, 2020, siRNA based drug design, quality, delivery and clinical translation, Nanomedicine, 29 Sajid, 2021, siRNA therapeutics for the therapy of COVID-19 and other coronaviruses, Mol. Pharm., 18, 2105, 10.1021/acs.molpharmaceut.0c01239 Couto, 2010, Viral vector-mediated RNA interference, Curr. Opin. Pharmacol., 10, 534, 10.1016/j.coph.2010.06.007 Karimi, 2016, Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems, Chem. Soc. Rev., 45, 1457, 10.1039/C5CS00798D Shen, 2018, Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics, Chem. Soc. Rev., 47, 1969, 10.1039/C7CS00479F Park, 2016, Galactosylated lipidoid nanoparticles for delivery of small interfering RNA to inhibit hepatitis C viral replication in vivo, Adv. Healthc. Mater., 5, 2931, 10.1002/adhm.201600416 Idris, 2021, A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19, Mol. Ther., 29, 2219, 10.1016/j.ymthe.2021.05.004 He, 2011, In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation, Small, 7, 271, 10.1002/smll.201001459 Zhu, 2015, DNA-capped Fe3O4/SiO2 magnetic mesoporous silica nanoparticles for potential controlled drug release and hyperthermia, RSC Adv., 5, 22365, 10.1039/C5RA00701A Lee, 2011, Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications, Acc. Chem. Res., 44, 893, 10.1021/ar2000259 Pinese, 2018, Sustained delivery of siRNA/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing, Acta Biomater., 76, 164, 10.1016/j.actbio.2018.05.054 Chen, 2009, Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells, Small, 5, 2673, 10.1002/smll.200900621 Du, 2023, Biodegradable silica nanocapsules enable efficient nuclear-targeted delivery of native proteins for cancer therapy, Biomaterials, 294, 10.1016/j.biomaterials.2023.122000 Dhama, 2020, COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics, Hum. Vaccines Immunother., 16, 1232, 10.1080/21645515.2020.1735227 Yesudhas, 2021, COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics, Infection, 49, 199, 10.1007/s15010-020-01516-2 Tao, 2015, Binding of CpG oligodeoxynucleotides to mesoporous silica nanoparticles for enhancing delivery efficiency, Microporous Mesoporous Mater., 204, 91, 10.1016/j.micromeso.2014.11.007 S.H. Gu, C.H. Yu, Y. Song, N.Y. Kim, E. Sim, J.Y. Choi, D.H. Song, G.H. Hur, Y.K. Shin, S.T. Jeong, A small interfering RNA lead targeting RNA-dependent RNA-polymerase effectively inhibit the SARS-CoV-2 infection in Golden Syrian hamster and Rhesus macaque, bioRxiv (2020) 190967. Elbashir, 2001, Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate, EMBO J., 20, 6877, 10.1093/emboj/20.23.6877 Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Sungnak, 2020, SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes, Nat. Med., 26, 681, 10.1038/s41591-020-0868-6 Yang, 2021, Human ACE2-functionalized gold "virus-trap" nanostructures for accurate capture of SARS-CoV-2 and single-virus SERS detection, Nanomicro Lett., 13, 109 Haldavnekar, 2018, Non plasmonic semiconductor quantum SERS probe as a pathway for in vitro cancer detection, Nat. Commun., 9, 3065, 10.1038/s41467-018-05237-x Zhang, 2022, Construction of a target MSNs drugcarrier loaded with siRNA(GLI1) and siRNA(SMO) aim at hedgehog signal pathway and the pharmacodynamic study of drug-carriers in the treatment of leukemia stem cells, Drug Deliv. Transl. Res., 12, 2463, 10.1007/s13346-020-00893-3 Ma, 2021, Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity, J. Cell. Mol. Med., 25, 7001, 10.1111/jcmm.16714 Liao, 2020, Distinct infection process of SARS-CoV-2 in human bronchial epithelial cell lines, J. Med. Virol., 92, 2830, 10.1002/jmv.26200 Yin, 2020, Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir, Science, 368, 1499, 10.1126/science.abc1560 Ari, 2020, Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19, Respir. Med., 167, 10.1016/j.rmed.2020.105987 Ari, 2021, Aerosol drug delivery to tracheotomized patients with COVID-19: pragmatic suggestions for clinicians, Can. J. Respir. Ther., 57, 49, 10.29390/cjrt-2020-05 Lin, 2023, GMI, a fungal immunomodulatory protein, ameliorates SARS-CoV-2 envelope protein-induced inflammation in macrophages via inhibition of MAPK pathway, Int. J. Biol. Macromol., 241, 10.1016/j.ijbiomac.2023.124648 Ma, 2023, Inhalable GSH-triggered nanoparticles to treat commensal bacterial infection in in situ lung tumors, ACS Nano, 17, 5740, 10.1021/acsnano.2c12165